All Industry News articles
-
NewsSLEEVER® and CARBIOS globally launch world’s first Home Compost biodegradable tamper evident seal
SLEEVER®, and CARBIOS have unveiled the first innovation to emerge from their partnership: SEELCAP® ONEGO, the world’s first Home Compost biodegradable tamper evident seal which integrates the encapsulated enzyme CARBIOS Active.
-
NewsBiofuel breakthrough: Rhodococcus strain N1-S transforms succinic acid production
A new study reveals that Rhodococcus aetherivorans strain N1-S boosts succinic acid yields by 6.5 times, promising a more efficient path to sustainable biofuels.
-
NewsFecal DNA testing could reduce global colonoscopy burden: experts
Experts gathered at the ICG 19 · Metagenomics for Health (ICG19·MH) & The 2nd MOHA Consortium have highlighted the global challenge of limited access to colonoscopy, the gold standard for CRC screening.
-
NewsFleming Initiative raises first £100m in the global fight against AMR
Three new partners have pledged additional funding and resources to the Fleming Initiative’s global effort to combat antimicrobial resistance (AMR), as leading medical expert Professor Lord Ara Darzi calls for tighter restrictions on the use of antibiotics.
-
NewsRwanda and BGI Genomics forge stronger ties in public health collaboration
Dr. Sabin Nsanzimana, the Minister of Health of Rwanda, along with Samuel Abikunda, Commercial Counsellor from the Embassy of Rwanda in China, led a high-level delegation to BGI Genomics on September 8, 2024.
-
NewsKorea University Vaccine Innovation Center teams with Moderna on mRNA-based hantavirus vaccine development
The Vaccine Innovation Center at Korea University College of Medicine has entered into a full-scale collaboration with global pharmaceutical company Moderna to develop an mRNA-based hantavirus vaccine.
-
NewsValneva and LimmaTech team up to accelerate tetravalent Shigella vaccine candidate
Valneva SE and LimmaTech Biologics AG have entered into a strategic partnership and exclusive licensing agreement for the development, manufacturing and commercialization of Shigella4V (S4V), a tetravalent bioconjugate vaccine candidate against shigellosis.
-
NewsResearchers collaborate for early monitoring of tar spot disease in corn
Insignum AgTech has begun a collaboration with researchers in Purdue University’s College of Agriculture and College of Engineering to create tools for farmers to identify early stages of tar spot disease outbreaks in their corn plants.
-
NewsFedEx opens first European Life Science Center in Veldhoven
Federal Express Corporation, the world’s largest express transportation company, has opened its first European Life Science Center in Veldhoven, the Netherlands. The specialised cooling facility opens global access for the healthcare industry.
-
NewsEnzyme-embedded PLA plastic can degrade in home-compost or methanization conditions.
A new enzyme-embedded material is proven to fully distintegrate and biodegrade at a much faster rate than the 26-week home-compost certification requirement and is shown to help produce more biomethane, another source of waste recovery.
-
NewsSRI is developing a new malaria treatment that aims to protect from the disease
The injectable formulation is affordable, easily administered, and could potentially provide months of protection from the potentially fatal disease.
-
NewsHighly pathogenic avian influenza A(H5N1) outbreak in Finnish fur farms
Highly pathogenic avian influenza (HPAI) A(H5N1) has been detected in animals on 27 fur farms in Finland. The outbreak, traced to wild birds, revealed significant virus adaptation to mammals and caused severe inflammation in the lungs, brains and livers.
-
NewsMicrobial agricultural inoculants market set to grow by $243.73 million from 2024-2028
The global microbial agricultural inoculants market size is estimated to grow by USD 243.73 million from 2024-2028, according to Technavio, with rising concerns over use of chemical fertilizers and pesticides in agriculture.
-
NewsRapid test for UTI wins $10m Longitude Prize on AMR to transform fight against superbugs
Sysmex Astrego’s PA-100 AST System has won the $10m (£8m) Longitude Prize on AMR. The winning test provides accurate antibiotic susceptibility results in 45 minutes – compared to the 2-3 day wait patients currently face.
-
NewsAI enables faster, more effective antibiotic treatment of sepsis
Sepsis is a life-threatening infection complication and accounts for 1.7 million hospitalizations and 350,000 deaths annually in the U.S. Fast and accurate diagnosis is critical, as mortality risk increases up to 8% every hour without effective treatment. Source: Ilanaer42 However, the current diagnostic standard is reliant on ...
-
NewsCollaboration garners new support to tackle high-value tuberculosis targets
A groundbreaking collaboration will combat global health challenges in tuberculosis through innovative technology.
-
NewsIVI starts technology transfer to Biological E. Limited to manufacture oral cholera vaccine for India and global markets
The International Vaccine Institute (IVI) has announced that it has commenced a technology transfer of simplified Oral Cholera Vaccine (OCV-S) to Biological E. Limited (BE), a leading India-based vaccines and pharmaceutical company.
-
NewsResearchers call for regulation of direct-to-consumer microbiome tests
Scientists argue that direct-to-consumer (DTC) microbiome tests lack analytical and clinical validity and require more federal regulation to prevent consumer harm.
-
NewsAMI unveils plans to launch educational series The Microbiologist Masterclass
Applied Microbiology International has announced it will be launching a new series of educational online content called The Microbiologist Masterclass. AMI will be teaming up with industry partners to present this series of educational assets including webinars, ‘how-to’ guides and the latest product information, plus practical tips and tricks to ...
-
NewsSK bioscience’s typhoid conjugate vaccine achieves WHO prequalification
SK bioscience and the International Vaccine Institute (IVI) announced that the typhoid conjugate vaccine developed by SK bioscience with technology transfer from IVI has achieved the World Health Organization prequalification (PQ).
